Hjem › Akut nyreskade › Pennsylvania
Kliniske studier for Akut nyreskade i Pennsylvania
8 studier for Akut nyreskade søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
- St Luke's University Hospital, Bethlehem
- Saint Mary Medical Center, Langhorne
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT05758077A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
- Research Site, Philadelphia
- Research Site, Pittsburgh
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07215702Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Pittsburgh, Pittsburgh
- Hillman Cancer Center, Pittsburgh
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06699849QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
- Children's Hospital of Philadelphia, Philadelphia
RekruttererObservasjonsstudie
Opp til 22 år · Alle kjønn · Oppdatert 14. mai 2026 · NCT06517810POCUS-Guided Diuresis for Decompensated Heart Failure
- UPMC East, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- UPMC Presbyterian, Pittsburgh
- og 2 flere
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT06921603A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
- University of Pennsylvania Health System, Philadelphia
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT06954129Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. des. 2025 · NCT04982419Nafamostat Efficacy in Phase 3 Registrational CRRT Study
- University of Pittsburgh Medical Center, Pittsburgh
Rekrutterer
Alder 18 til 80 · Alle kjønn · Oppdatert 15. okt. 2025 · NCT06150742Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.